Methotrexate use and liver outcomes in psoriasis and rheumatoid arthritis patients: A commentary on Risk of liver disease in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis receiving methotrexate: A population-based study''

Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/24125

Title:	Methotrexate use and liver outcomes in psoriasis and rheumatoid arthritis patients: A commentary on Risk of liver disease in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis receiving methotrexate: A population-based study''
Authors:	Gau, SY
Date:	2021
Issue Date:	2022-08-05T10:43:31Z (UTC)
Publisher:	MOSBY-ELSEVIER
ISSN:	0190-9622
URI:	http://dx.doi.org/10.1016/j.jaad.2021.07.069 https://www.webofscience.com/wos/woscc/full-record/WOS:000723647700036 https://ir.csmu.edu.tw:8080/handle/310902500/24125
Relation:	JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY ,2021 ,v85 ,issue6 ,E400-E400
Appears in Collections:	[中山醫學大學研究成果] 其他文獻

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	149	View/Open